Chronic hepatitis B prognostic markers other than pre-treatment viral load predicted composite treatment outcome | Zendy

Myo Nyein Aung | Zendy; Wattana Leowattana | Zendy; Khine Nwe Win | Zendy; Noppadon Tangpukdee | Zendy; Sant Muangnoicharoen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Chronic hepatitis B prognostic markers other than pre-treatment viral load predicted composite treatment outcome

Author(s) -

Myo Nyein Aung,

Wattana Leowattana,

Khine Nwe Win,

Noppadon Tangpukdee,

Sant Muangnoicharoen

Publication year - 2013

Publication title -

the journal of infection in developing countries

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.322

H-Index - 49

eISSN - 2036-6590

pISSN - 1972-2680

DOI - 10.3855/jidc.2759

Subject(s) - viral load , medicine , hbeag , gastroenterology , confidence interval , hepatitis b , retrospective cohort study , chronic hepatitis , immunology , hepatitis b virus , hbsag , human immunodeficiency virus (hiv) , virus

Chronic hepatitis B (CHB) is a globally common infectious disease. Its clinical course is complicated. In Southeast Asia, nucleos(t)ide analogues (NA) are commonly used drugs for CHB treatment. Composite treatment outcome has often been used in CHB clinical practice, but rarely predicted epidemiologically. This study aimed to compare the composite treatment outcome between CHB patients with low and high treatment-naïve viral load, and to identify its predictors

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research